Bioheart, Inc. (BHRT) Executes Major Financing Agreement
Located in Sunrise, Florida, Bioheart is a company committed to the discovery, development and commercialization of autologous cell therapies for the treatment of an array of diseases. Today, Bioheart took a major step towards prominence with the announcement they have entered into a $3M standby equity purchase agreement which was previously announced in October. Bioheart plans to use the proceeds of each of the draws to continue its FDA approved trials with the Florida investor agreeing to purchase $3M of BHRT common stock upon request. The financing agreement is subject to certain conditions, which include the registration of those shares…